Status:

COMPLETED

Asthma and Obesity: Observational

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborating Sponsors:

University of Colorado, Denver

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Asthma

Obesity

Eligibility:

All Genders

21-64 years

Brief Summary

Obesity is associated with poor asthma control and greater healthcare utilization and costs. In this study the researchers will examine the biologic and behavioral interrelationships between these con...

Detailed Description

The objective of this study is to examine novel biological and behavioral pathways that may explain the association of obesity with asthma morbidity, and develop and pilot test educational and counsel...

Eligibility Criteria

Inclusion

  • \>21 years with a diagnosis of asthma made by a health care provider and evidence of airway reactivity (increase in FEV1 \>12% and \>200 ml after bronchodilators or positive methacholine test) in prior lung function testing or baseline spirometry;
  • prescribed an asthma controller medication;
  • English or Spanish speaking.

Exclusion

  • chronic obstructive lung disease (COPD) or other chronic respiratory illness; - \>15 pack-year smoking history because of the possibility of undiagnosed COPD;
  • diagnosis of dementia identified in the clinical record.

Key Trial Info

Start Date :

May 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 30 2021

Estimated Enrollment :

333 Patients enrolled

Trial Details

Trial ID

NCT03460834

Start Date

May 1 2016

End Date

April 30 2021

Last Update

May 6 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Colorado Denver, Anschutz Medical Campus

Aurora, Colorado, United States, 80045

2

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029